Search

Jonathan G. Sterrett

Examiner (ID: 9327)

Most Active Art Unit
3623
Art Unit(s)
3623
Total Applications
825
Issued Applications
274
Pending Applications
34
Abandoned Applications
517

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5368410 [patent_doc_number] => 20090305969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Skin Repair Accelerating Therapeutic Agent Containing Desacyl Ghrelin and Derivatives Thereof as Active Ingredient' [patent_app_type] => utility [patent_app_number] => 12/085220 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7356 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305969.pdf [firstpage_image] =>[orig_patent_app_number] => 12085220 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/085220
Skin Repair Accelerating Therapeutic Agent Containing Desacyl Ghrelin and Derivatives Thereof as Active Ingredient Nov 20, 2006 Abandoned
Array ( [id] => 5343238 [patent_doc_number] => 20090181888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Skin Repair Accelerating Therapeutic Agent Containing Ghrelin and Derivatives Thereof or Substance Acting On GHS-R1a as Active Ingredient' [patent_app_type] => utility [patent_app_number] => 12/085221 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8237 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181888.pdf [firstpage_image] =>[orig_patent_app_number] => 12085221 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/085221
Skin Repair Accelerating Therapeutic Agent Containing Ghrelin and Derivatives Thereof or Substance Acting On GHS-R1a as Active Ingredient Nov 20, 2006 Abandoned
Array ( [id] => 5253888 [patent_doc_number] => 20070135344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Novel growth factor and a genetic sequence encoding same' [patent_app_type] => utility [patent_app_number] => 11/602055 [patent_app_country] => US [patent_app_date] => 2006-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 9373 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135344.pdf [firstpage_image] =>[orig_patent_app_number] => 11602055 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/602055
Novel growth factor and a genetic sequence encoding same Nov 19, 2006 Abandoned
Array ( [id] => 4823026 [patent_doc_number] => 20080227711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Cxc-Chemokine Antagonists' [patent_app_type] => utility [patent_app_number] => 12/067221 [patent_app_country] => US [patent_app_date] => 2006-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 23829 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227711.pdf [firstpage_image] =>[orig_patent_app_number] => 12067221 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067221
CXC-chemokine antagonists isolated from Rhipicephalus sanguineus Oct 29, 2006 Issued
Array ( [id] => 4970733 [patent_doc_number] => 20070110735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Methods for regulating angiogenesis and vascular integrity using trk receptor ligands' [patent_app_type] => utility [patent_app_number] => 11/589659 [patent_app_country] => US [patent_app_date] => 2006-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14199 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20070110735.pdf [firstpage_image] =>[orig_patent_app_number] => 11589659 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/589659
Methods for increasing capillary density and maintaining viability of microvascular cardiac endothelial cells using trk receptor ligands Oct 29, 2006 Issued
Array ( [id] => 5224697 [patent_doc_number] => 20070253963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Epithelial cell specific growth factor keratinocyte growth factor (KGF)' [patent_app_type] => utility [patent_app_number] => 11/585862 [patent_app_country] => US [patent_app_date] => 2006-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15351 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20070253963.pdf [firstpage_image] =>[orig_patent_app_number] => 11585862 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/585862
Epithelial cell specific growth factor keratinocyte growth factor (KGF) Oct 24, 2006 Abandoned
Array ( [id] => 5410657 [patent_doc_number] => 20090124556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Peptides Exhibiting Efficacies of Improvement in Skin Conditions or Treatment of Periodental Diseases' [patent_app_type] => utility [patent_app_number] => 12/083970 [patent_app_country] => US [patent_app_date] => 2006-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9295 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124556.pdf [firstpage_image] =>[orig_patent_app_number] => 12083970 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/083970
Method for improving skin conditions Oct 23, 2006 Issued
Array ( [id] => 13651 [patent_doc_number] => 07807628 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Therapeutic agent for dentin-pulp complex regeneration' [patent_app_type] => utility [patent_app_number] => 12/083734 [patent_app_country] => US [patent_app_date] => 2006-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 6674 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807628.pdf [firstpage_image] =>[orig_patent_app_number] => 12083734 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/083734
Therapeutic agent for dentin-pulp complex regeneration Oct 18, 2006 Issued
Array ( [id] => 4550374 [patent_doc_number] => 07820396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Method for determining atopic dermatitis using protein marker' [patent_app_type] => utility [patent_app_number] => 12/090644 [patent_app_country] => US [patent_app_date] => 2006-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 24 [patent_no_of_words] => 12698 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820396.pdf [firstpage_image] =>[orig_patent_app_number] => 12090644 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/090644
Method for determining atopic dermatitis using protein marker Oct 18, 2006 Issued
Array ( [id] => 5052097 [patent_doc_number] => 20070032642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Novel genes and their use in the modulation of obesity, diabetes and energy imbalance' [patent_app_type] => utility [patent_app_number] => 11/544140 [patent_app_country] => US [patent_app_date] => 2006-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18381 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032642.pdf [firstpage_image] =>[orig_patent_app_number] => 11544140 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/544140
Novel genes and their use in the modulation of obesity, diabetes and energy imbalance Oct 5, 2006 Abandoned
Array ( [id] => 5527728 [patent_doc_number] => 20090197805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'Insulin receptor antagonists and related compositions, uses and methods' [patent_app_type] => utility [patent_app_number] => 12/089222 [patent_app_country] => US [patent_app_date] => 2006-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17687 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197805.pdf [firstpage_image] =>[orig_patent_app_number] => 12089222 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/089222
Insulin receptor antagonists and related compositions, uses and methods Oct 2, 2006 Abandoned
Array ( [id] => 5126388 [patent_doc_number] => 20070238659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'VARIANTS OF VASCULAR ENDOTHELIAL CELL GROWTH FACTORS HAVING ANTAGONISTIC PROPERTIES, NUCLEIC ACIDS ENCODING THE SAME AND HOST CELLS COMPRISING THOSE NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 11/536547 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16830 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238659.pdf [firstpage_image] =>[orig_patent_app_number] => 11536547 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/536547
VARIANTS OF VASCULAR ENDOTHELIAL CELL GROWTH FACTORS HAVING ANTAGONISTIC PROPERTIES, NUCLEIC ACIDS ENCODING THE SAME AND HOST CELLS COMPRISING THOSE NUCLEIC ACIDS Sep 27, 2006 Abandoned
Array ( [id] => 5242847 [patent_doc_number] => 20070021342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Wound Healing' [patent_app_type] => utility [patent_app_number] => 11/535032 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19667 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021342.pdf [firstpage_image] =>[orig_patent_app_number] => 11535032 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/535032
Wound Healing Sep 24, 2006 Abandoned
Array ( [id] => 5005492 [patent_doc_number] => 20070203063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS INCLUDING VARIANTS OF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR HAVING ALTERERD PHARMACOLOGICAL PROPERTIES' [patent_app_type] => utility [patent_app_number] => 11/533301 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12168 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203063.pdf [firstpage_image] =>[orig_patent_app_number] => 11533301 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/533301
PHARMACEUTICAL COMPOSITIONS INCLUDING VARIANTS OF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR HAVING ALTERERD PHARMACOLOGICAL PROPERTIES Sep 18, 2006 Abandoned
Array ( [id] => 6455082 [patent_doc_number] => 20100145441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'THERAPEUTIC AGENTS FOR ANGIOGENESIS-RELATED DISEASES COMPRISING CHONDROMODULIN-I AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 12/067593 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18840 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20100145441.pdf [firstpage_image] =>[orig_patent_app_number] => 12067593 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067593
THERAPEUTIC AGENTS FOR ANGIOGENESIS-RELATED DISEASES COMPRISING CHONDROMODULIN-I AS ACTIVE INGREDIENT Sep 14, 2006 Abandoned
Array ( [id] => 5453196 [patent_doc_number] => 20090069233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Agonist Peptides of Basic Fibroblast Growth Factor (bFGF) and the Method of Reduction of Wrinkles on Skin, Darkening of Hair and Acceleration of Wound Healing' [patent_app_type] => utility [patent_app_number] => 12/066786 [patent_app_country] => US [patent_app_date] => 2006-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2409 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069233.pdf [firstpage_image] =>[orig_patent_app_number] => 12066786 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/066786
Agonist Peptides of Basic Fibroblast Growth Factor (bFGF) and the Method of Reduction of Wrinkles on Skin, Darkening of Hair and Acceleration of Wound Healing Sep 10, 2006 Abandoned
Array ( [id] => 5258758 [patent_doc_number] => 20070212390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Protease-resistant forms of VEGF-D, method of making and method of use' [patent_app_type] => utility [patent_app_number] => 11/517290 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8761 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212390.pdf [firstpage_image] =>[orig_patent_app_number] => 11517290 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/517290
Protease-resistant forms of VEGF-D, method of making and method of use Sep 7, 2006 Abandoned
Array ( [id] => 5135994 [patent_doc_number] => 20070077623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/518609 [patent_app_country] => US [patent_app_date] => 2006-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 139 [patent_figures_cnt] => 139 [patent_no_of_words] => 117361 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20070077623.pdf [firstpage_image] =>[orig_patent_app_number] => 11518609 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/518609
Secreted and transmembrane polypeptides and nucleic acids encoding the same Sep 6, 2006 Abandoned
Array ( [id] => 6593554 [patent_doc_number] => 20100048465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Peptide mimics of melanocyte stimulating hormone' [patent_app_type] => utility [patent_app_number] => 11/991121 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19246 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048465.pdf [firstpage_image] =>[orig_patent_app_number] => 11991121 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/991121
Peptide mimics of melanocyte stimulating hormone Aug 31, 2006 Issued
Array ( [id] => 6055100 [patent_doc_number] => 20110111460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Method for Making Mature Insulin Polypeptides' [patent_app_type] => utility [patent_app_number] => 12/063692 [patent_app_country] => US [patent_app_date] => 2006-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13172 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20110111460.pdf [firstpage_image] =>[orig_patent_app_number] => 12063692 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/063692
Method for making mature insulin polypeptides Aug 14, 2006 Issued
Menu